Published in J Chromatogr on November 01, 1978
Kinetics of isosorbide dinitrate and relationships to pharmacological effects. Br J Clin Pharmacol (1981) 0.92
Prolonged plasma half-life after oral isosorbide dinitrate in patients with angina pectoris. Br J Clin Pharmacol (1983) 0.75
Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res (1994) 3.43
The efficacy of dihydrotestosterone transdermal gel before primary hypospadias surgery: a prospective, controlled, randomized study. J Urol (2007) 2.85
Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med (1993) 2.85
Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system. Br J Cancer (1999) 2.34
Detection of prostate cancer with a microbubble ultrasound contrast agent. Lancet (2001) 2.23
Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production. J Exp Med (1997) 2.14
Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue. J Pathol (2000) 2.11
Evaluation and management of renal injuries: consensus statement of the renal trauma subcommittee. BJU Int (2004) 2.09
Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. Cancer Res (1998) 2.07
Urinary incontinence in the elderly and age-dependent apoptosis of rhabdosphincter cells. Lancet (1999) 1.92
Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Mol Endocrinol (1993) 1.73
Androgen receptors in prostate cancer. Endocr Relat Cancer (2002) 1.71
New onset hypertension after extracorporeal shock wave lithotripsy: age related incidence and prediction by intrarenal resistive index. J Urol (1997) 1.70
Distant metastases from prostatic carcinoma express androgen receptor protein. Cancer Res (1995) 1.63
Neobladder emptying failure in males: incidence, etiology and therapeutic options. J Urol (2006) 1.61
Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole. Eur J Clin Pharmacol (1994) 1.60
Urethra-sparing cystectomy and orthotopic urinary diversion in women with malignant pelvic tumors. Cancer (2001) 1.58
Testicular torsion: late results with special regard to fertility and endocrine function. J Urol (1980) 1.52
Metastatic lesions from prostate cancer do not express oestrogen and progesterone receptors. J Pathol (1997) 1.52
Sildenafil modulates hemodynamics and pulmonary gas exchange. Am J Respir Crit Care Med (2001) 1.50
Laparoscopic surgery for pheochromocytoma: adrenalectomy, partial resection, excision of paragangliomas. J Urol (1998) 1.47
Genes differentially expressed in prostate cancer. BJU Int (2004) 1.45
Zoledronic acid influences growth, migration and invasive activity of prostate cancer cells in vitro. Prostate Cancer Prostatic Dis (2012) 1.43
Regulation of prostatic growth and function by peptide growth factors. Prostate (1996) 1.42
Lich-Gregoir reimplantation causes less discomfort than Politano-Leadbetter technique: Results of a prospective, randomized, pain scale-oriented study in a pediatric population. Eur Urol (2005) 1.39
Extracorporeal shock wave lithotripsy versus ureteroscopy for distal ureteral calculi: a prospective randomized study. J Urol (1999) 1.33
Androgen receptor--an update of mechanisms of action in prostate cancer. Urol Res (2000) 1.25
Age, prostate-specific antigen, and digital rectal examination as determinants of the probability of having prostate cancer. Urology (2001) 1.24
The female urethral sphincter: a morphological and topographical study. J Urol (1998) 1.24
Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous testicular carcinoma: long-term outcome. J Urol (2000) 1.24
Radical prostatectomy: the value of preoperative, individually labeled apical biopsies. J Urol (2000) 1.23
Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides. Cancer Gene Ther (2000) 1.21
Uptake of azithromycin by various cells and its intracellular activity under in vivo conditions. Antimicrob Agents Chemother (1996) 1.21
Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells. J Urol (1999) 1.20
Treatment of giant ancient pelvic schwannoma. Tech Urol (2001) 1.20
Expression, structure, and function of androgen receptor in advanced prostatic carcinoma. Prostate (1998) 1.19
Posttraumatic posterior urethral stricture repair: anatomy, surgical approach and long-term results. J Urol (1997) 1.19
Bacillus Calmette-Guérin mycobacteria stimulate human blood dendritic cells. Int J Cancer (1997) 1.19
Guidelines for the diagnosis and treatment of benign prostatic hyperplasia: a comparative, international overview. Urology (2001) 1.18
Laparoscopic nephron sparing surgery for small renal cell carcinoma. J Urol (1998) 1.17
Androgen receptor status of lymph node metastases from prostate cancer. Prostate (1996) 1.16
Crossing vessels at the ureteropelvic junction: detection with contrast-enhanced color Doppler imaging. Radiology (1999) 1.16
Neurological and neuropsychiatric dysfunction in primary Sjögren's syndrome. Acta Neurol Scand (1994) 1.15
Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype. Clin Cancer Res (2001) 1.13
Transurethral prostatectomy: mortality and morbidity. Prostate (1996) 1.13
Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer. Prostate (2000) 1.12
Isolated right-sided varicocele as a salvage pathway for portal hypertension. Int J Clin Pract (2005) 1.08
Light microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia. J Urol (1979) 1.08
Primary lymphatic metastatic spread in testicular cancer occurs ventral to the lumbar vessels. Urology (2002) 1.07
Morphometry in experimental pathology: methods, baseline data and applications. Int Rev Exp Pathol (1976) 1.07
Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score. J Urol (2007) 1.07
Distribution of orally administered azithromycin in various blood compartments. Int J Clin Pharmacol Ther (1994) 1.07
Laparoscopic partial adrenalectomy in patients with aldosterone-producing adenomas: indications, technique, and results. Urology (2003) 1.06
Transforming growth factors-beta 1 and beta 2 in serum and urine from patients with bladder carcinoma. J Urol (1996) 1.05
Orgotein: a new antiinflammatory metalloprotein drug evaluation of clinical efficacy and safety in inflammatory conditions of the urinary tract. Int Urol Nephrol (1974) 1.04
Mechanisms of endocrine therapy-responsive and -unresponsive prostate tumours. Endocr Relat Cancer (2005) 1.02
DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction. Prostate (1993) 1.01
Age dependent apoptosis and loss of rhabdosphincter cells. J Urol (2000) 1.01
Molecular biology of the androgen receptor: from molecular understanding to the clinic. Eur Urol (2001) 1.01
Interaction of azithromycin and human phagocytic cells. Uptake of the antibiotic and the effect on the survival of ingested bacteria in phagocytes. Arzneimittelforschung (1989) 1.01
Androgen signal transduction and prostatic carcinoma. World J Urol (1994) 1.00
Quality of life after cystectomy and orthotopic neobladder versus ileal conduit urinary diversion. World J Urol (2000) 1.00
Management of benign prostatic hyperplasia with particular emphasis on aromatase inhibitors. J Steroid Biochem Mol Biol (1993) 1.00
Upgrading of Gleason score 6 prostate cancers on biopsy after prostatectomy in the low and intermediate tPSA range. Prostate Cancer Prostatic Dis (2009) 0.99
Changing diagnostic and therapeutic concepts in high-flow priapism. Int J Impot Res (2005) 0.99
Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factor. Eur Urol (1995) 0.98
Laparoscopic and retroperitoneoscopic repair of ureteropelvic junction obstruction. Urology (1996) 0.98
The reaction between organic nitrates and sulfhydryl compounds. A possible model system for the activation of organic nitrates. Mol Pharmacol (1985) 0.97
Anatomic and functional studies of the male and female urethral sphincter. World J Urol (2000) 0.97
Laparoscopic surgery for stage T1 renal cell carcinoma: radical nephrectomy and wedge resection. Eur Urol (2000) 0.96
Point mutation in the DNA binding domain of the androgen receptor in two families with Reifenstein syndrome. Am J Hum Genet (1992) 0.96
Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancer. Urology (1998) 0.96
Human renal-cell carcinoma tissue contains dendritic cells. Int J Cancer (1996) 0.96
Rationale and technique of nerve sparing radical cystectomy before an orthotopic neobladder procedure in women. J Urol (1995) 0.95
Influence of exposure to moderate altitude on the plasma concentraton of cortisol, aldosterone, renin, testosterone, and gonadotropins. Eur J Appl Physiol Occup Physiol (1980) 0.95
Retracted Transurethral ultrasonography-guided injection of adult autologous stem cells versus transurethral endoscopic injection of collagen in treatment of urinary incontinence. World J Urol (2007) 0.95
Laparoscopic heminephroureterectomy in pediatric patients. J Urol (1997) 0.94
Bioavailability of fluconazole in the skin after oral medication. Mycoses (1995) 0.94
Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostate. Prostate (1997) 0.94
Prospective randomized trial using laser acupuncture versus desmopressin in the treatment of nocturnal enuresis. Eur Urol (2001) 0.94
Mutant androgen receptors in prostatic tumors distinguish between amino-acid-sequence requirements for transactivation and ligand binding. Int J Cancer (1995) 0.93
Left-sided laparoscopic adrenalectomy. Scand J Urol Nephrol (1993) 0.93
Influence of the antibiotics erythromycin and azithromycin on the pharmacokinetics and pharmacodynamics of midazolam. Arzneimittelforschung (1996) 0.93
Frequency and clinical significance of transition zone cancer in prostate cancer screening. Prostate (1997) 0.93
Expression of transforming growth factors beta-1, beta 2 and beta 3 in human bladder carcinomas. Br J Cancer (1997) 0.92
Anatomy and innervation of the rhabdosphincter of the male urethra. Prostate (1996) 0.92
Therapeutic effects of luteinizing hormone releasing hormone (LH-RH) in cryptorchidism. Andrologia (1974) 0.92
Treatment of multiple sclerosis with mitoxantrone. Eur Arch Psychiatry Clin Neurosci (1992) 0.91
Influence of concomitant food intake on the gastrointestinal absorption of fluconazole and itraconazole in Japanese subjects. Int J Clin Pharmacol Res (1994) 0.90
Comparative pharmacokinetics of fluconazole and of itraconazole in Japanese and in German subjects. Int J Clin Pharmacol Ther (1995) 0.90
In vitro generation of CD83+ human blood dendritic cells for active tumor immunotherapy. Exp Hematol (1997) 0.90
The risk of urethral tumors in female bladder cancer: can the urethra be used for orthotopic reconstruction of the lower urinary tract? J Urol (1995) 0.89
Characterisation of a collecting duct carcinoma by cytogenetic analysis and comparative genomic hybridisation. Int J Oncol (1998) 0.89
Levels of fluconazole in serum, stratum corneum, epidermis-dermis (without stratum corneum) and eccrine sweat. Clin Exp Dermatol (1993) 0.89
Laparoscopic Fenger plasty. J Endourol (2000) 0.89
[Functions of intrinsic defense against anaerobic bacteria in healthy probands and patients with chronic-septic granulomatosis]. Klin Wochenschr (1987) 0.89